B-CELL PRECURSOR BONE-MARROW RECONSTITUTION AFTER BONE-MARROW TRANSPLANTATION

被引:32
|
作者
LEITENBERG, D [1 ]
RAPPEPORT, JM [1 ]
SMITH, BR [1 ]
机构
[1] YALE UNIV,SCH MED,DEPT INTERNAL MED,NEW HAVEN,CT 06510
关键词
BONE MARROW TRANSPLANTATION; IMMUNOGLOBULIN GENE REARRANGEMENT; IMMUNOPHENOTYPE; PRE-B CELLS;
D O I
10.1093/ajcp/102.2.231
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Bone marrow transplantation is characterized by a prolonged period of humoral immunodeficiency in which many patients have abnormal circulating B-cell subsets, and oligoclonal and monoclonal gammopathies. In this study we examine B-cell precursor reconstitution in the posttransplantation marrow. Within 1 month after transplantation there is a marked increase in the percentage of immature B cells (to 80% of marrow lymphocytes), which can persist for more than 1 year. The increase in B-cell precursors is seen in both adults and children and appears to be independent of age. These cells have a normal precursor B-cell surface antigenic phenotype (CD19+, CD10+, CD20 negative to dim) and generally express very little CD34. No monoclonal or oligoclonal immunoglobulin gene rearrangements are detected in these cells, which enables them to be easily distinguishable from common precursor B-cell acute lymphocytic leukemia lymphoblasts.
引用
收藏
页码:231 / 236
页数:6
相关论文
共 50 条
  • [21] IMMUNOSUPPRESSIVE THERAPY IN BONE-MARROW TRANSPLANTATION
    BARRETT, AJ
    IMMUNOLOGY LETTERS, 1991, 29 (1-2) : 81 - 87
  • [22] BONE-MARROW TRANSPLANTATION AND STEM-CELL PREPARATION
    STANGEL, W
    KADAR, JG
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1995, 22 : 115 - 115
  • [23] BIOLOGICAL THERAPIES IN BONE-MARROW TRANSPLANTATION
    KOCHUPILLAI, V
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1995, 101 : 129 - 133
  • [24] BONE-MARROW TRANSPLANTATION FOR SICKLE-CELL-ANEMIA
    ABBOUD, MR
    JACKSON, SM
    BARREDO, J
    BEATTY, J
    LAVER, J
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1994, 16 (01): : 86 - 89
  • [25] THE TRANSIENT APPEARANCE OF SMALL BLASTOID CELLS IN THE MARROW AFTER BONE-MARROW TRANSPLANTATION
    KOBAYASHI, SD
    SEKI, K
    SUWA, N
    KOAMA, C
    YAMAMOTO, T
    AIBA, K
    MARUTA, A
    MATSUZAKI, M
    FUKAWA, H
    KANAMORI, H
    HARANO, H
    MIYASHITA, H
    KODAMA, F
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1991, 96 (02) : 191 - 195
  • [26] PARVOVIRUS-B19 INFECTION AND BONE-MARROW TRANSPLANTATION
    FRICKHOFEN, N
    ARNOLD, R
    HERTENSTEIN, B
    WIESNETH, M
    YOUNG, NS
    ANNALS OF HEMATOLOGY, 1992, 64 : A121 - A124
  • [27] PREVENTION OF VIRAL-INFECTIONS AFTER BONE-MARROW TRANSPLANTATION
    SCHULER, U
    EHNINGER, G
    ANNALS OF HEMATOLOGY, 1992, 64 : A152 - A157
  • [28] BRONCHIOLITIS OBLITERANS AFTER BONE-MARROW TRANSPLANTATION - THE EFFECT OF PRECONDITIONING
    PAZ, HL
    CRILLEY, P
    TOPOLSKY, DL
    COLL, WX
    PATCHEFSKY, A
    BRODSKY, I
    RESPIRATION, 1993, 60 (02) : 109 - 114
  • [29] HEMATOPOIETIC ENGRAFTMENT AND GRAFT FAILURE AFTER BONE-MARROW TRANSPLANTATION
    QUINONES, RR
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1993, 15 (01): : 3 - 17
  • [30] FIBROSING CHOLESTATIC HEPATITIS AND HBV AFTER BONE-MARROW TRANSPLANTATION
    COOKSLEY, WGE
    MCIVOR, CA
    BIOMEDICINE & PHARMACOTHERAPY, 1995, 49 (03) : 117 - 124